Draft, review, and negotiate master services agreements, commercial and service agreements, SaaS and software license agreements, data privacy agreements and DPAs, vendor and consulting agreements, reseller agreements, development/developer agreements, and amendments, escalating novel or high-risk issues as appropriate. Our software and scientists incorporate modern advances in scientific understanding, drug development experience, data analysis, and AI resulting in significant opportunities to decrease the cost and increase the probability of success for new drug approval and commercialization.